Company intelligence / Profile preview

InVivo Biosystems

Eugene, Oregon, United Statesinvivobiosystems.com ↗

Ownership: Private
Development stage: Preclinical

Overview

InVivo Biosystems provides advanced genome editing and phenotypic analysis services using C. elegans and zebrafish models to accelerate drug discovery and development, particularly in neurological, metabolic, and rare genetic diseases. Their proprietary platforms enable rapid target identification and multimodal therapeutic screening with relevant behavioral/molecular endpoints in vivo. The company does not have its own clinical pipeline but supports client programs at the preclinical/discovery stage.

Therapeutic areas: Metabolic DisordersRare DiseasesNeurology
Modalities: Genome editing (CRISPR)Phenotypic screening platformsCustom animal models (C. elegans, zebrafish)
Industry: Drug Discovery Services

Partnerships

Not specifically listed; works with pharmaceutical companies, nutraceutical companies, biotech firms, academic institutions globally.

Beyond the preview

Go deeper on InVivo Biosystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InVivo Biosystems.

Explore the full profile